Michael J. Sofia - Dec 1, 2021 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Role: Chief Scientific Officer
Signature: /s/ David C. Hastings as attorney-in-fact for Michael J. Sofia
Stock symbol: ABUS
Transactions as of: Dec 1, 2021
Transactions value $: -$1,018,000
Form type: 4
Date filed: 12/3/2021, 03:02 PM
Next filing: Jan 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABUS	Common Shares	Sale	-$1.02M	-200K	-13.3%	$5.09	1.3M	Dec 1, 2021	Direct	F1
holding	ABUS	Common Shares						167K	Dec 1, 2021	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021.
F2	These shares are owned by the Irrevocable Deeds of Trust of Michael J. Sofia dated July 6, 2020 (the "Trusts"). The reporting person's wife and adult children are both the Trustees and the beneficiaries of the Trusts. The reporting person disclaims beneficial ownership of the shares owned by the Trusts and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021.

These shares are owned by the Irrevocable Deeds of Trust of Michael J. Sofia dated July 6, 2020 (the "Trusts"). The reporting person's wife and adult children are both the Trustees and the beneficiaries of the Trusts. The reporting person disclaims beneficial ownership of the shares owned by the Trusts and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.